Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

bioAffinity Technologies (BIAF) Change in Accured Expenses (2022 - 2025)

bioAffinity Technologies (BIAF) has disclosed Change in Accured Expenses for 4 consecutive years, with $733442.0 as the latest value for Q4 2025.

  • Quarterly Change in Accured Expenses rose 48.33% to $733442.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $319267.0 through Dec 2025, up 28.27% year-over-year, with the annual reading at $319267.0 for FY2025, 28.27% up from the prior year.
  • Change in Accured Expenses for Q4 2025 was $733442.0 at bioAffinity Technologies, up from -$63487.0 in the prior quarter.
  • The five-year high for Change in Accured Expenses was $733442.0 in Q4 2025, with the low at -$339090.0 in Q3 2022.
  • Average Change in Accured Expenses over 4 years is $62282.8, with a median of -$28818.0 recorded in 2022.
  • The sharpest move saw Change in Accured Expenses skyrocketed 645.7% in 2023, then crashed 476.22% in 2025.
  • Over 4 years, Change in Accured Expenses stood at $67859.0 in 2022, then surged by 645.7% to $506025.0 in 2023, then decreased by 2.28% to $494470.0 in 2024, then surged by 48.33% to $733442.0 in 2025.
  • According to Business Quant data, Change in Accured Expenses over the past three periods came in at $733442.0, -$63487.0, and -$322701.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.